Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
Missouri Bans Intoxicating Hemp Products as Federal Crackdown Spreads
Missouri legislature sends bill to governor banning intoxicating hemp sales starting November 12, following federal Republican push against delta-8 THC products.
Minnesota Cannabis Market Hits $50M as Adult-Use Overtakes Medical Sales
Minnesota's recreational cannabis market reaches $50M milestone in just five months, with adult-use sales now consistently outpacing medical segment.
CV Sciences Plunges 12.4% as CBD Stock Hits New Distress Levels
CV Sciences shares tumbled to $0.04 on elevated volume, marking another concerning decline for the struggling CBD company.
TPB Shrugs Off FDA PMTA Setback as Core Business Drives Resilience
Turning Point Brands maintains operational strength despite regulatory headwinds affecting tobacco product approval pathways.
Missouri House Backs Psychedelics Research for Veterans, First Responders
Missouri lawmakers advance legislation requiring state-funded study of psilocybin therapy for depression and substance abuse treatment among military veterans and emergency personnel.
Trees Corp Stock Surges 14.3% Despite Minimal Trading Volume
CANN shares jumped to $0.03 on modest volume of 69,626 shares, highlighting the volatility typical of micro-cap cannabis stocks.
Blueberries Medical Corp Surges 19% Despite Trading at Penny Levels
BBRRF jumped 19.2% to $0.01 on elevated volume of 26,100 shares, though the international cannabis company continues trading at distressed levels.
Cannabis Rescheduling Push Gains Medical Research Momentum on Capitol Hill
Congressional testimony highlights how federal cannabis rescheduling could accelerate rare disease research, potentially expanding addressable markets for medical operators.
Congressional Hearing Links Cannabis Research to National Security Concerns
House committee explores marijuana rescheduling as solution to rare disease treatment gaps and Chinese pharmaceutical dependence.
CBD Global Sciences Surges 16.4% as OTC Stock Sees Trading Revival
CBDNF climbs to $0.04 on elevated volume of 770 shares, marking significant percentage gain for the micro-cap CBD company.
Lifeist Wellness Surges 24.5% Despite Micro-Cap Volatility
LFSWF climbed to $0.03 on modest volume of 10,645 shares, highlighting the volatile nature of micro-cap cannabis stocks.
PharmaCielo Plunges 26.4% as Cannabis Stock Hits Near-Lows
PharmaCielo shares tumbled to $0.04 on elevated volume, marking another significant decline for the struggling cannabis company.
Trump Budget Includes Medical Cannabis Protections for States
President includes federal protections for state medical marijuana programs in latest budget proposal, signaling continued policy support.
Trump Budget Includes Medical Cannabis Protections Amid Policy Shift
Federal budget proposal signals continued protection for state medical programs, driving optimism across cannabis sector as regulatory clarity improves.
Aurora Cannabis Partners with Bioxyne for Global Manufacturing Push
ACB expands international reach through manufacturing deal with Bioxyne, targeting overseas markets as domestic cannabis revenues plateau.
NY Home Cultivation Rules Create Mixed Signals for Cannabis Market
New York's home grow regulations highlight ongoing complexity in state cannabis frameworks, potentially impacting licensed operator revenue streams.
Aurora Cannabis Taps Bioxyne for Global Manufacturing Partnership
Aurora Cannabis expands international reach through manufacturing deal with rapidly growing Bioxyne, marking strategic shift toward asset-light operations.
Tech Billionaire's AI Play Signals Shift in Cannabis Investment Landscape
Druckenmiller's Alphabet purchase highlights growing tech integration in cannabis as institutional investors eye AI-driven opportunities in the sector.
Medical Cannabis Costs Create Patient Access Crisis in Canada
Rising medical cannabis prices force patients to choose between treatment and financial stability, highlighting systemic issues in Canada's medical program.
Medical Imaging Advances Could Accelerate Cannabis Research Capabilities
New FDA-cleared CT technology may enhance clinical research infrastructure for cannabis studies as industry seeks medical validation.